The French retail bank will buy the Portuguese lender from its majority owner Lone Star in the latest cross-border deal in European banking. A chip-manufacturing spinoff could help solve some of the ...

23andMe struck a deal last month with Regeneron Pharmaceuticals Inc., but Wojcicki complained about the bidding process, ...

Anne Wojcicki won a bid to purchase the genetic testing platform through her nonprofit TTAM Research Institute. The $305M deal was part of a bankruptcy auction, beating out offers from Regeneron ...

To delete your data from 23andMe, you need to log in to your account and then follow these steps: Navigate to the Settings ...

The California-based nonprofit founded by the former 23andMe CEO is set to close the $305 million deal in coming weeks.

Welcome to the future, folks—where AI is regulated, genetic testing companies have more plot twists than a soap opera, and ...

Beleaguered genetic testing company 23andMe announced Friday that it has reached an agreement to sell itself to TTAM Research ...

A.I. may push ad creatives from producing to consulting. At Cannes, Monks, a marketing technology agency, will showcase a new ...

Wojcicki, a co-founder and former CEO of 23andMe, is buying ‘substantially all’ of the company’s assets through a nonprofit.

Anne Wojcicki, the co-founder and former CEO of 23andMe, will purchase the bankrupt company’s assets for $305 million, the genetic testing company said Friday. Regeneron Pharmaceuticals had agreed to ...

The genetic testing company 23andMe is poised to be sold to a nonprofit run by the company's former chief executive Anne ...

Regeneron is backing away from buying the DNA-testing company after a nonprofit controlled by co-founder Wojcicki made a higher bid. The private-equity firm plans to bid against rival Advent ...